Can prebiotic sodas curb your appetite? new study investigates
NCT ID NCT07362563
First seen Jun 24, 2026 · Last updated Jul 16, 2026 · Updated 4 times
Summary
This pilot study is testing whether drinking prebiotic sodas can increase hormones that make you feel full, compared to a regular soda. Fifteen healthy adults will drink different sodas and have their blood and stomach emptying measured over two hours. The goal is to see if the added fiber in these sodas has a noticeable effect on appetite and digestion.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- prebiotic soda
- What this could lead to
- If successful, this could show that prebiotic sodas help manage appetite and blood sugar, pointing toward a simple dietary aid for weight control.
- What could go wrong
- This is a very small pilot study (15 people) looking at short-term effects only. Results may not apply to the general population or lead to long-term benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Feb 2026
- Finished
-
May 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-60 years, inclusive. * BMI between 18.0 and 30.0 kg/m2. * Stable weight in the last 3 months (+/-5kg). * Willing to abstain from unusual strenuous exercise, consuming alcoholic drinks and from taking fiber supplements for 24 hours before study days. * Willing to refrain from smoking tobacco or e-cigarettes, and using marijuana in any form for 12h before and during study visits. * Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator. * Subjects must be eligible to receive income in Canada and be covered by a health insurance plan such as Ontario Health Insurance Plan (OHIP). Exclusion Criteria: * Self-reported pregnant or breastfeeding women. * Subjects with a history of severe food allergies or an allergy to acetaminophen. * Known history of diabetes, any gastrointestinal disorder that alters the absorption of nutrients, liver disease, or the presence of any health condition, illness or drug use that increases risk to the subject or to others or may affect the results, as judged by the Qualified Investigator (QI). * Subjects who are currently or in the last 2 months have been on oral or injectable GLP-1 receptor agonist (RA) medications. * Subjects who consume more than 14 alcoholic drinks per week, or more than 5 alcoholic drinks on any one occasion. * Subjects who have been on antibiotic therapy in the last 2 months. * Subjects taking the blood thinning drug warfarin. * Subjects who are habitual users of the following supplements in the past 30 days: berberine, curcumin, cinnamon, resveratrol, and gardenia. * Subjects which have undergone major surgery in the last 3 months. * Unwillingness or inability to comply with experimental procedures and to follow Inquis safety guidelines. * Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement, or lifestyle modification.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Satiety in healthy volunteers are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inquis Clinical Research
Toronto, Ontario, M5C 2N8, Canada